D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 86 Citations 35,469 259 World Ranking 7296 National Ranking 3986

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Cancer
  • Gene

Elizabeth M. Brunt mainly focuses on Internal medicine, Gastroenterology, Fatty liver, Nonalcoholic fatty liver disease and Pathology. Her Internal medicine study focuses mostly on Liver disease, Liver biopsy, Steatosis, Biopsy and Fibrosis. Her study in Gastroenterology is interdisciplinary in nature, drawing from both Steatohepatitis, Disease and Insulin resistance.

Elizabeth M. Brunt has included themes like Odds ratio, Cross-sectional study, Placebo and Vitamin E in her Fatty liver study. Her work deals with themes such as Body mass index, Family medicine, Mass screening, Chronic liver disease and Metabolic syndrome, which intersect with Nonalcoholic fatty liver disease. She has researched Pathology in several fields, including Canals of Hering and Liver Stem Cell.

Her most cited work include:

  • Design and validation of a histological scoring system for nonalcoholic fatty liver disease (6077 citations)
  • Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions (2947 citations)
  • The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association (2522 citations)

What are the main themes of her work throughout her whole career to date?

Elizabeth M. Brunt focuses on Internal medicine, Gastroenterology, Pathology, Nonalcoholic fatty liver disease and Fatty liver. Her Internal medicine study frequently draws connections to other fields, such as Endocrinology. Elizabeth M. Brunt combines subjects such as Fibrosis, Biopsy and Surgery with her study of Gastroenterology.

In her work, Carcinoma and Radiology is strongly intertwined with Hepatocellular carcinoma, which is a subfield of Pathology. Her Nonalcoholic fatty liver disease research incorporates themes from Body mass index, Metabolic syndrome, Insulin resistance, Prospective cohort study and Severity of illness. Her study with Fatty liver involves better knowledge in Disease.

She most often published in these fields:

  • Internal medicine (60.12%)
  • Gastroenterology (40.48%)
  • Pathology (38.37%)

What were the highlights of her more recent work (between 2014-2021)?

  • Internal medicine (60.12%)
  • Nonalcoholic fatty liver disease (24.17%)
  • Gastroenterology (40.48%)

In recent papers she was focusing on the following fields of study:

Her scientific interests lie mostly in Internal medicine, Nonalcoholic fatty liver disease, Gastroenterology, Pathology and Steatosis. Her work carried out in the field of Internal medicine brings together such families of science as Endocrinology and Oncology. Her biological study spans a wide range of topics, including Biopsy, Liver biopsy, Insulin resistance, Fibrosis and Prospective cohort study.

Elizabeth M. Brunt works mostly in the field of Liver biopsy, limiting it down to topics relating to Liver disease and, in certain cases, Disease, as a part of the same area of interest. Her Gastroenterology study incorporates themes from Body mass index, Placebo, Non alcoholic, Metabolic syndrome and Stage. Her studies deal with areas such as Gallbladder and MEDLINE as well as Pathology.

Between 2014 and 2021, her most popular works were:

  • The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. (2005 citations)
  • Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial (1266 citations)
  • Nonalcoholic fatty liver disease (293 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Gene

Her primary scientific interests are in Nonalcoholic fatty liver disease, Internal medicine, Gastroenterology, Pathology and Fibrosis. Her Nonalcoholic fatty liver disease research incorporates elements of Steatosis, Biopsy, Liver biopsy, Confidence interval and Receiver operating characteristic. Her Internal medicine study which covers Surgery that intersects with Cross-sectional study.

The various areas that Elizabeth M. Brunt examines in her Gastroenterology study include Steatohepatitis, Fatty liver, Placebo, Metabolic syndrome and Insulin resistance. Elizabeth M. Brunt interconnects Retinopathy, Hyperintensity and Cell type in the investigation of issues within Pathology. In her study, which falls under the umbrella issue of Fibrosis, Odds ratio is strongly linked to Cirrhosis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

David E. Kleiner;Elizabeth M. Brunt;Mark Van Natta;Cynthia Behling.
Hepatology (2005)

7710 Citations

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

Elizabeth M Brunt;Christine G Janney;Adrian M Di Bisceglie;Brent A Neuschwander-Tetri.
The American Journal of Gastroenterology (1999)

4937 Citations

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

Naga Chalasani;Zobair Younossi;Joel E. Lavine;Anna Mae Diehl.
Hepatology (2012)

4068 Citations

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

Arun J. Sanyal;Naga Chalasani;Kris V. Kowdley;Arthur McCullough.
The New England Journal of Medicine (2010)

2708 Citations

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.

Naga Chalasani;Zobair Younossi;Joel E. Lavine;Michael Charlton.
Hepatology (2018)

2442 Citations

The Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

Naga Chalasani;Zobair Younossi;Joel E. Lavine;Anna Mae Diehl.
Gastroenterology (2012)

1782 Citations

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

Brent A Neuschwander-Tetri;Rohit Loomba;Arun J Sanyal;Joel E Lavine.
The Lancet (2015)

1658 Citations

A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells

Ken Cadwell;John Y. Liu;Sarah L. Brown;Hiroyuki Miyoshi.
Nature (2008)

1462 Citations

Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone

Brent A. Neuschwander-Tetri;Elizabeth M. Brunt;Kent R. Wehmeier;Dana Oliver.
Hepatology (2003)

1078 Citations

Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents: The TONIC Randomized Controlled Trial

Joel E. Lavine;Jeffrey B. Schwimmer;Mark L. Van Natta;Jean P. Molleston;Jean P. Molleston.
JAMA (2011)

987 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Elizabeth M. Brunt

Valerio Nobili

Valerio Nobili

Sapienza University of Rome

Publications: 209

Rohit Loomba

Rohit Loomba

University of California, San Diego

Publications: 204

Arun J. Sanyal

Arun J. Sanyal

Virginia Commonwealth University

Publications: 177

Zobair M. Younossi

Zobair M. Younossi

Inova Health System

Publications: 164

Quentin M. Anstee

Quentin M. Anstee

Newcastle University

Publications: 147

Luca Valenti

Luca Valenti

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Publications: 140

Christopher D. Byrne

Christopher D. Byrne

National Institute for Health Research

Publications: 132

Leon A. Adams

Leon A. Adams

University of Western Australia

Publications: 125

Claude B. Sirlin

Claude B. Sirlin

University of California, San Diego

Publications: 124

Kenneth Cusi

Kenneth Cusi

University of Florida

Publications: 118

Vincent Wai-Sun Wong

Vincent Wai-Sun Wong

Chinese University of Hong Kong

Publications: 117

Naga Chalasani

Naga Chalasani

Indiana University

Publications: 113

Elisabetta Bugianesi

Elisabetta Bugianesi

University of Turin

Publications: 112

Jacob George

Jacob George

University of Sydney

Publications: 103

Pierre Bedossa

Pierre Bedossa

Université Paris Cité

Publications: 97

Ariel E. Feldstein

Ariel E. Feldstein

University of California, San Diego

Publications: 96

Trending Scientists

John G. Harris

John G. Harris

University of Florida

Parag A. Agashe

Parag A. Agashe

Qualcomm (United States)

Masahiro Goto

Masahiro Goto

Kyushu University

Peter Varga

Peter Varga

TU Wien

Rolf Boelens

Rolf Boelens

Utrecht University

Kimitsuna Watanabe

Kimitsuna Watanabe

National Institute of Advanced Industrial Science and Technology

Fredrik Pontén

Fredrik Pontén

Uppsala University

Eric J. Smart

Eric J. Smart

University of Kentucky

Lai-yung Ruby Leung

Lai-yung Ruby Leung

Pacific Northwest National Laboratory

Richard Washington

Richard Washington

University of Oxford

Antoinette Jobert

Antoinette Jobert

Inserm : Institut national de la santé et de la recherche médicale

Alfred L. Nuttall

Alfred L. Nuttall

Oregon Health & Science University

Ståle Einarsen

Ståle Einarsen

University of Bergen

George E. Bigelow

George E. Bigelow

Johns Hopkins University School of Medicine

Kurt Straif

Kurt Straif

International Agency For Research On Cancer

Something went wrong. Please try again later.